Deutsche Bank initiates coverage on Biogen-IDEC (Nasdaq: BIIB) with a Hold rating and $60 price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE